Dimension Capital II, L.P. - 08 May 2026 Form 4 Insider Report for Odyssey Therapeutics, Inc. (ODTX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 May 2026, 17:37:36 UTC
Prior SEC filing
12 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
s/ Adam Goulburn - for Dimension Capital II, L.P., By: Dimension Capital II GP, LP, its general partner, By: Adam Goulburn, Member

Key filing fact

Dimension Capital II, L.P. filed Form 4 for Odyssey Therapeutics, Inc. (ODTX) on 12 May 2026.

Key facts

  • This page summarizes Dimension Capital II, L.P.'s Form 4 filing for Odyssey Therapeutics, Inc. (ODTX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 May 2026, 17:37.

Change

  • Previous filing in this sequence was filed on 12 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002040933 Primary reporting owner

Dimension Capital II, L.P.

Relationship
Director
Address
632 BROADWAY, SUITE 801, NEW YORK
Signature
s/ Adam Goulburn - for Dimension Capital II, L.P., By: Dimension Capital II GP, LP, its general partner, By: Adam Goulburn, Member
Signature date
12 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ODTX transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+1,709,543
Change %
+333%
Price
Shares after
2,222,405
Date
08 May 2026
Ownership
Direct
Footnotes
F1, F2, F3
ODTX transaction

Common Stock

Purchase

Transaction value
Shares
+1,111,111
Change %
+50%
Price
$18.00*
Shares after
3,333,516
Date
08 May 2026
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ODTX transaction Derivative

Series D Convertible Preferred Stock

Conversion of derivative security

Transaction value
Shares
-16,611,626
Change %
-100%
Price
Shares after
0
Date
08 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,709,543
Exercise price
Footnotes
F1, F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration.

Footnote F2

Held directly by Dimension Capital II, L.P. ("Dimension Capital II"). Dimension Management, L.P. ("Dimension Management") is the investment advisor to Dimension Capital II. Dimension Management GP, L.P. is the general partner of Dimension Management, and Dimension Management GP, LLC ("Dimension Management GP") is the general partner of Dimension Management GP, L.P. Dimension Capital II GP, LLC ("Dimension Capital II GP") is the general partner to the general partner of Dimension Capital II. Adam Goulburn, Zavain Dar, and Nan Li are members of each of Dimension Management GP and Dimension Capital II GP. Mr. Li serves on the Issuer's board of directors.

Footnote F3

Each of Dimension Management, Dimension Management GP, Dimension Capital II GP, Mr. Goulburn, Mr. Dar, and Mr. Li disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein.

Footnote F4

Gives effect to the 1-for-9.7170 reverse stock split effected prior to the closing of the Issuer's initial public offering.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .